cbdMD, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on AMEX, led by CEO T. Ronan Kennedy, with a market cap of $6.9M.
Common questions about cbdMD, Inc.
cbdMD, Inc. is scheduled to report earnings for Q2 2026 on May 14, 2026. Analysts estimate revenue of $5.3M.
cbdMD, Inc. has approximately 52 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.